What predicts high risk acute graft-versus-host disease (GVHD) at onset?: Identification of those at highest risk by a novel acute GVHD risk score

British Journal of Haematology

Volumn 157, Issue 6, 2012, Pages 732-741

  MacMillan, Margaret L ^a   Defor, Todd E ^a,b   Weisdorf, Daniel J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Acute GVHD; Grading system; Haematopoietic cell transplantation; Prognosis; Risk

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; MEPREDNISONE; PREDNISONE; STEROID; TACROLIMUS; TRIAMCINOLONE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SURVIVAL TIME; TREATMENT DURATION; TREATMENT RESPONSE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; ORGAN SPECIFICITY; PREDNISONE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84861527625     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09114.x     Document Type: Article

References (21)

1. Armitage, P. (1955) Tests for linear trends in proportions and frequencies. Biometrics, 11, 375-386.
2. Barker, J.N., Davies, S.M., DeFor, T., Ramsay, N.K., Weisdorf, D.J. & Wagner, J.E. (2001) Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood, 97, 2957-2961.
3. Barker, J.N., Weisdorf, D.J., DeFor, T.E., Blazar, B.R., McGlave, P.B., Miller, J.S., Verfaillie, C.M. & Wagner, J.E. (2005) Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood, 105, 1343-1347.
4. Cahn, J.Y., Klein, J.P., Lee, S.J., Milpied, N., Blaise, D., Antin, J.H., Leblond, V., Ifrah, N., Jouet, J.P., Loberiza, F., Ringden, O., Barrett, A.J., Horowitz, M.M. & Socie, G. (2005) Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood, 106, 1495-1500.
5. Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Stastistical Society, 34, 187-220.
6. Fine, J.P. & Gray, R.J. (1999) A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association, 94, 496-509.
7. Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G. & Thomas, E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation, 18, 295-304.
8. Hings, I.M., Filipovich, A.H., Miller, W.J., Blazar, B.L., McGlave, P.B., Ramsay, N.K., Kersey, J.H. & Weisdorf, D.J. (1993) Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial. Transplantation, 56, 577-580.
9. Hings, I.M., Severson, R., Filipovich, A.H., Blazar, B.R., Kersey, J.H., Ramsay, N.K., McGlave, P.B. & Weisdorf, D.J. (1994) Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation. Transplantation, 58, 437-442.
10. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
11. Lin, D.Y. (1997) Non-parametric inference for cumulative incidence functions in competing risks studies. Statistics in Medicine, 16, 901-910.
12. MacMillan, M.L., Weisdorf, D.J., Wagner, J.E., DeFor, T.E., Burns, L.J., Ramsay, N.K., Davies, S.M. & Blazar, B.R. (2002a) Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biology of Blood and Marrow Transplantation, 8, 387-394.
13. MacMillan, M.L., Weisdorf, D.J., Davies, S.M., DeFor, T.E., Burns, L.J., Ramsay, N.K., Wagner, J.E. & Blazar, B.R. (2002b) Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease. Biology of Blood and Marrow Transplantation, 8, 40-46.
14. MacMillan, M.L., DeFor, T.E. & Weisdorf, D.J. (2010) The best endpoint for acute GVHD treatment trials. Blood, 115, 5412-5417.
15. Martino, R., Romero, P., Subira, M., Bellido, M., Altes, A., Sureda, A., Brunet, S., Badell, I., Cubells, J. & Sierra, J. (1999) Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. International Bone Marrow Transplant Registry. Bone Marrow Transplantation, 24, 283-287.
16. Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J. & Thomas, E.D. (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplantation, 15, 825-828.
17. Rowlings, P.A., Przepiorka, D., Klein, J.P., Gale, R.P., Passweg, J.R., Henslee-Downey, P.J., Cahn, J.Y., Calderwood, S., Gratwohl, A., Socie, G., Abecasis, M.M., Sobocinski, K.A., Zhang, M.J. & Horowitz, M.M. (1997) IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. British Journal of Haematology, 97, 855-864.
18. Weisdorf, D., Haake, R., Blazar, B., Miller, W., McGlave, P., Ramsay, N., Kersey, J. & Filipovich, A. (1990a) Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. Blood, 75, 1024-1030.
19. Weisdorf, D.J., Snover, D.C., Haake, R., Miller, W.J., McGlave, P.B., Blazar, B., Ramsay, N.K., Kersey, J.H. & Filipovich, A. (1990b) Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood, 76, 624-629.
20. Weisdorf, D.J., Hurd, D., Carter, S., Howe, C., Jensen, L.A., Wagner, J., Stablein, D., Thompson, J. & Kernan, N.A. (2003) Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review. Biology of Blood and Marrow Transplantation, 9, 512-518.
21. Weisdorf, D., Spellman, S., Haagenson, M., Horowitz, M., Lee, S., Anasetti, C., Setterholm, M., Drexler, R., Maiers, M., King, R., Confer, D. & Klein, J. (2008) Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biology of Blood and Marrow Transplantation, 14, 748-758.